GC Wellbeing

▶ To display a large media façade on its Yong-in R&D Center

YONGIN, South Korea, 18 April 2023 – GC Biopharma (006280.KS), a leading provider of biopharmaceutical products in South Korea, takes part in a campaign to celebrate World Hemophilia Day.

The company announced that a large media façade had lit up its R&D Center building located in Yong-in, Gyeonggi-do, Korea on 16th and 17th to mark the World Hemophilia Day.

World Federation of Hemophilia (WFH) has been commemorating World Hemophilia Day on April 17th every year since 1989 and runs campaigns to increase the understanding and awareness about hemophilia and other bleeding disorders.

This year’s slogan, “Access for All: Prevention of bleeds as the global standard of care” is designed to emphasize the importance of improved access to treatment for all people around the world with bleeding disorders.

Hemophilia is a rare genetic bleeding disorder in which the blood lacks its capacity to clot. Around 2,500 people are registered as hemophilia patients in Korea. GC Biopharma, since its foundation, has been putting continuous efforts in providing better treatment conditions for people with hemophilia.

“We will continue our R&D efforts for improving treatment access for all patients with hemophilia while carrying out other awareness campaigns to increase social understanding about the bleeding disorders.”, said an official from GC Biopharma.